Patent DE427496C successfully refreshed from Google Patents.
Patent US4820628A successfully refreshed from Google Patents.
US4820628A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Fetal lung maturity test employing lamellar body solubilization
Assignee: Oregon Health & Science University
•
Filing: 1986-05-30
•
Granted: 1989-04-11
•
Expires: 2006-05-30
Abstract
Abstract The lamellar body solubilization test (LBST) is a rapid and simple indicator of fetal lung maturity. The amniotic fluid contains lamellar bodies, the presence of which can be correlated to maturation of lung tissue. The test is conducted by measuring a difference in an optical property (turbidity, light scatter, innate or added fluorescence) of a sample of amniotic fluid or other physical property affected by the presence of particulate bodies suspended in a liquid, either 1) kinetically (rate method) or 2) as an end point method (pre- and post-), due to the unravelling or solubilization of the lamellar bodies caused by subjecting the sample to a physical or chemical agent, e.g., detergent or heat. The change in that property either rate of change or delta, by the destruction of the lamellar body structure provides an accurate indication of the concentration and size of the lamellar bodies in the sample of amniotic fluid, which in turn provides a good indication of fetal lung maturity.
Inventors
- 👤 Stephen L. Weitz
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 10:04
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/52; C; C12; C12Q; C12Q1/00; C12Q1/34; C12Q1/44
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
114 words
A method for assaying fetal or neonatal lung maturity which comprises the steps of (a) measuring at least one physical property of a fluid containing the lamellar bodies present in a defined amount of a mother's amniotic fluid, which property is one which is affected by the concentration of particulate bodies which are suspended in a liquid; (b) destroying partially or totally the lamellar body structure of the lamellar bodies in that liquid; and (c) measuring the change or rate of change in that physical property of the liquid resulting from such partial or total destruction of the lamellar body structure said change or rate of change being an indication of said lung maturity.
Claim 2
Independent Claim
114 words
A method for assaying fetal or neonatal lung maturity which comprises the steps of (a) measuring at least one physical property of a fluid containing the lamellar bodies present in a defined amount of a mother's amniotic fluid, which property is one which is affected by the concentration of particulate bodies which are suspended in a liquid; (b) destroying partially or totally the lamellar body structure of the lamellar bodies in that liquid; and (c) measuring the change or rate of change in that physical property of the liquid resulting from such partial or total destruction of the lamellar body structure said change or rate of change being an indication of said lung maturity.
Claim 3
Dependent Claim
17 words
A method according to claim 1, wherein the lamellar body structure is destroyed by a solubilizing reagent.
Claim 4
Dependent Claim
13 words
A method according to claim 2, wherein the solubilizing agent is an enzyme.
Claim 5
Dependent Claim
13 words
A method according to claim 2, wherein the solubilizing agent is a surfactant.
Claim 6
Dependent Claim
15 words
A method according to claim 4, wherein the surfactant is an ionic or nonionic detergent.
Claim 7
Dependent Claim
13 words
A method according to claim 1, wherein the surfactant is an organic solvent.
Claim 8
Dependent Claim
16 words
A method according to claim 1, wherein the lamellar body structure is destroyed with ultrasonic energy.
Claim 9
Dependent Claim
15 words
A method according to claim 1, wherein the lamellar body structure is destroyed with heat.
Claim 10
Dependent Claim
36 words
A method according to claim 1, wherein the physical property of the amniotic fluid which is measured includes at least one member of the group consisting of absorbance, turbidity, light scatter, innate fluorescence and added fluorescence.
Claim 11
Dependent Claim
19 words
A method according to claim 1, wherein the physical property of the amniotic fluid which is measured is absorbance.
Claim 12
Dependent Claim
20 words
A method according to claim 1, wherein the absorbance wavelength of light is in the range 190 to 700 nanometers.
Claim 13
Dependent Claim
15 words
A method according to claim 1, wherein the change in the physical property is measured.
Claim 14
Dependent Claim
17 words
A method according to claim 1, wherein the rate of change in the physical property is measured.
Claim 15
Dependent Claim
29 words
A method according to claim 1, wherein the lamellar body structure is destroyed by a solubilizing surfactant; and wherein the change in optical density at 340 nm is measured.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-04-10 | 1992-10-10 | 1993-04-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-04-10 | 1996-10-10 | 1997-04-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-04-10 | 2000-10-10 | 2001-04-11 | $7700.00 | Window Closed / Lapsed |